These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562 [TBL] [Abstract][Full Text] [Related]
17. Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes. Naftali-Shani N; Molotski N; Nevo-Caspi Y; Arad M; Kuperstein R; Amit U; Huber I; Zeltzer LA; Levich A; Abbas H; Monserrat L; Paret G; Leor J Circulation; 2018 Dec; 138(23):2721-2723. PubMed ID: 30571272 [No Abstract] [Full Text] [Related]
18. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes. Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261 [TBL] [Abstract][Full Text] [Related]
19. DeepNEU: cellular reprogramming comes of age - a machine learning platform with application to rare diseases research. Danter WR Orphanet J Rare Dis; 2019 Jan; 14(1):13. PubMed ID: 30630505 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes. Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]